CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Feb. 20, 2019--
AptarGroup, Inc. (NYSE:ATR) today reported fourth quarter and annual
results for 2018.
Fourth Quarter 2018 Summary
-
Reported sales increased 9%
-
Core sales, excluding currency and acquisition effects, grew 7%
-
Reported earnings per share decreased 19% to $0.62 compared to
prior year earnings per share of $0.77
-
Adjusted earnings per share increased 19% to $0.92 compared to
prior year adjusted earnings per share of $0.77 (including comparable
exchange rates)
-
Reported net income decreased 18%
-
Adjusted EBITDA increased 20%
-
Pharma segment earnings included a positive impact of approximately
$6 million related to a gain on the sale of an equity investment
-
Food + Beverage segment earnings included a negative impact of
approximately $2 million related to the write-off of a prepaid license
fee
Annual 2018 Summary
-
Reported sales increased 12%
-
Core sales, excluding currency and acquisition effects, grew 8%
-
Reported earnings per share decreased 12% to $3.00 compared to
prior year earnings per share of $3.41
-
Adjusted earnings per share increased 13% to $4.00 compared to
prior year adjusted earnings per share of $3.54 (including comparable
exchange rates)
-
Reported net income decreased 11% and reported net income margin (%
of net sales) was 7% compared to 9% a year ago
-
Adjusted EBITDA increased 16% and adjusted EBITDA margin was 20%
compared to 19% a year ago
-
Acquired strategic technologies (CSP Technologies and Reboul)
-
2018 was our 25th consecutive year of
paying an increased dividend
Fourth Quarter Results
For the quarter ended December 31, 2018, reported sales increased to
$685 million compared to $626 million in the prior year. Core sales,
excluding the negative impact from changes in currency exchange rates
and positive acquisition effects, increased approximately 7%.
|
|
|
Fourth Quarter Segment Sales Analysis
|
|
(Change Over Prior Year)
|
|
|
|
|
|
|
Beauty +
|
|
|
|
|
|
Food +
|
|
|
Total
|
|
|
|
|
Home
|
|
|
Pharma
|
|
|
Beverage
|
|
|
AptarGroup
|
|
Core Sales Growth
|
|
|
4%
|
|
|
15%
|
|
|
0%
|
|
|
7%
|
|
Acquisitions
|
|
|
1%
|
|
|
12%
|
|
|
13%
|
|
|
6%
|
|
Currency Effects (1) |
|
|
(4%)
|
|
|
(4%)
|
|
|
(3%)
|
|
|
(4%)
|
|
Total Reported Sales Growth
|
|
|
1%
|
|
|
23%
|
|
|
10%
|
|
|
9%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) - Currency effects are approximated by translating last year's
amounts at this year's foreign exchange rates.
|
|
|
Commenting on the quarter, Stephan Tanda, President and CEO, said, “Core
sales growth reached the high end of our long-term target range as two
of our three business segments grew and the third was impacted by lower
custom tooling sales compared to a year ago. I am pleased with this top
line performance over what was a strong period a year ago when each
segment posted double-digit core growth. Our Pharma segment had another
excellent quarter while our Beauty + Home segment performed well, and
our Food + Beverage segment underperformed in the Chinese beverage
market. Demand for our innovative solutions was again broad-based and we
increased core sales in each geographic region and across each of our
end markets other than the beverage market. We implemented price
increases to pass-along raw material cost increases but faced cost
headwinds and some operational challenges in our Beauty + Home segment.
We intend to remain diligent in our cost pass-through and turnaround
efforts. In addition, the integration of CSP Technologies is progressing
well and we are pleased to offer CSP’s active packaging solutions as
part of Aptar’s ever-growing portfolio of differentiating solutions.”
Aptar reported earnings per share of $0.62 compared to $0.77 reported a
year ago. Current year adjusted earnings per share, excluding
restructuring expenses, acquisition costs and purchase accounting
adjustments, were $0.92 and up 19% from the prior year adjusted earnings
per share, including comparable exchange rates, of $0.77.
Annual Results
For the year ended December 31, 2018, reported sales increased 12% to
$2.76 billion from $2.47 billion a year ago. Core sales, excluding the
positive impact from changes in currency exchange rates and acquisition
effects, increased approximately 8%.
|
|
|
Annual Segment Sales Analysis
|
|
(Change Over Prior Year)
|
|
|
|
|
|
|
Beauty +
|
|
|
|
|
|
Food +
|
|
|
Total
|
|
|
|
|
Home
|
|
|
Pharma
|
|
|
Beverage
|
|
|
AptarGroup
|
|
Core Sales Growth
|
|
|
7%
|
|
|
12%
|
|
|
5%
|
|
|
8%
|
|
Acquisitions
|
|
|
1%
|
|
|
4%
|
|
|
4%
|
|
|
2%
|
|
Currency Effects (1) |
|
|
1%
|
|
|
2%
|
|
|
1%
|
|
|
2%
|
|
Total Reported Sales Growth
|
|
|
9%
|
|
|
18%
|
|
|
10%
|
|
|
12%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) - Currency effects are approximated by translating last year's
amounts at this year's foreign exchange rates.
|
|
|
Tanda commented on the annual results, “We had an excellent year overall
with strong top line growth across each segment, each geographic region
and in all end markets other than beverage, which was slightly down on
lower custom tooling sales. We continued to benefit from our Commercial
Excellence and Transformation initiatives, especially in our Beauty +
Home segment. We also faced inflationary cost increases that had
negative effects on our profitability and we are working diligently to
increase prices to offset these headwinds. Aptar’s strategic priorities
continue to forge a path for success and we are committed to helping our
customers win in their markets with the industry’s broadest portfolio of
differentiated services and solutions.”
For the year 2018, Aptar reported earnings per share of $3.00 compared
to $3.41 reported a year ago. Current year adjusted earnings per share,
excluding restructuring expenses, acquisition costs and purchase
accounting adjustments, were $4.00 and up 13% from prior year adjusted
earnings per share, including comparable exchange rates, of $3.54.
Business Transformation
The business transformation in Aptar’s Beauty + Home segment and key
corporate functions is progressing as planned with the goal to become a
more agile and customer-focused organization. Our commercial initiatives
are yielding positive results on our Beauty + Home segment’s top line
growth. In addition, other initiatives are also contributing to margin
improvements though their impacts were offset by headwinds including the
timing of raw material cost pass-throughs and isolated operational
challenges in the fourth quarter.
Outlook
Commenting on Aptar’s outlook, Tanda said, “We anticipate positive sales
momentum continuing into the first quarter, and we expect each segment
to post core sales growth over the prior year. We are addressing
near-term opportunities and challenges while we plan for the long-term.
Aptar is a leader in the global packaging and drug delivery industries
and we are committed to playing a part in creating a more sustainable
future for generations to come. I am pleased to say that we are
accelerating our efforts and taking the next steps toward this goal. We
recently announced that we have signed the New Plastics Economy Global
Commitment and joined the World Business Council for Sustainable
Development. While our portfolio already offers fully recyclable and
post-consumer recycled resin solutions, we are looking forward to having
an even greater impact towards a truly circular economy.”
Our current first quarter earnings per share guidance range reflects a
higher tax rate and higher estimated outstanding share count than the
prior year and it also assumes negative foreign currency translation
effects as the euro has weakened considerably from a year ago. Aptar
expects earnings per share for the first quarter, excluding any
restructuring costs, to be in the range of $0.95 to $1.00 and this
guidance is based on an effective tax rate range of 29% to 31%. The
midrange of this guidance represents an improvement of approximately 9%
over the prior year earnings per share excluding restructuring expenses
and adjusted to comparable currency and tax rates. Prior year reported
earnings per share were $0.92.
Cash Dividend
As previously reported, the Board declared on January 17, 2019 a
quarterly cash dividend of $0.34 per share. The payment date is February
20, 2019, to stockholders of record as of January 30, 2019.
Open Conference Call
There will be a conference call on Thursday, February 21, 2019 at 8:00
a.m. Central Time to discuss the Company’s fourth quarter and annual
results for 2018. The call will last approximately one hour. Interested
parties are invited to listen to a live webcast by visiting the Investor
Relations page at www.aptar.com.
Replay of the conference call can also be accessed for a limited time on
the Investor Relations page of the website.
Aptar is a leading global supplier of a broad range of innovative
dispensing, sealing and active packaging solutions for the beauty,
personal care, home care, prescription drug, consumer health care,
injectables, food and beverage markets. Aptar uses insights, design,
engineering and science to create innovative packaging technologies that
build brand value for its customers, and, in turn, make a meaningful
difference in the lives, looks, health and homes of people around the
world. Aptar is headquartered in Crystal Lake, Illinois and has over
14,000 dedicated employees in 18 different countries. For more
information, visit www.aptar.com.
Presentation of Non-GAAP Information
This press release refers to certain non-GAAP financial measures,
including current year adjusted earnings per share and adjusted EBITDA,
which exclude the impact of restructuring costs, acquisition costs and
purchase accounting adjustments that affected inventory values. Core
sales and adjusted earnings per share also neutralize the impact of
foreign currency translation effects when comparing current results to
the prior year. Non-GAAP financial measures may not be comparable to
similarly titled non-GAAP financial measures provided by other
companies. Aptar’s management believes these non-GAAP financial measures
provide useful information to our investors because they allow for a
better period over period comparison of operating results by removing
the impact of items that, in management’s view, do not reflect Aptar’s
core operating performance. These non-GAAP financial measures also
provide investors with certain information used by Aptar’s management
when making financial and operational decisions. These non-GAAP
financial measures should not be considered in isolation or as a
substitute for GAAP financial results, but should be read in conjunction
with the unaudited condensed consolidated statements of income and other
information presented herein. A reconciliation of non-GAAP financial
measures to the most directly comparable GAAP measures is included in
the accompanying tables. Our outlook is provided on a non-GAAP basis
because certain reconciling items are dependent on future events that
either cannot be controlled, such as tax and exchange rates, or reliably
predicted because they are not part of the Company's routine activities,
such as restructuring and acquisition costs.
This press release contains forward-looking statements, including
certain statements set forth under the “Outlook” and “Business
Transformation” sections of this press release. Words such as “expects,”
“anticipates,” “believes,” “estimates,” “future,” “potential” and other
similar expressions or future or conditional verbs such as “will,”
“should,” “would” and “could” are intended to identify such
forward-looking statements. Forward-looking statements are made pursuant
to the safe harbor provisions of Section 27A of the Securities Act of
1933 and Section 21E of the Securities Exchange Act of 1934 and are
based on our beliefs as well as assumptions made by and information
currently available to us. Accordingly, our actual results may differ
materially from those expressed or implied in such forward-looking
statements due to known or unknown risks and uncertainties that exist in
our operations and business environment including, but not limited to:
the successful integration of the CSP Technologies business; the impact
of tax reform legislation including changes in tax rates and other
tax-related events or transactions that could impact our effective tax
rate; the execution of the business transformation; economic conditions
worldwide including potential deflationary and inflationary conditions
in regions we rely on for growth; political conditions worldwide;
significant fluctuations in foreign currency exchange rates; changes in
customer and/or consumer spending levels; financial conditions of
customers and suppliers; consolidations within our customer or supplier
bases; fluctuations in the cost of materials, components and other input
costs; the availability of raw materials and components; our ability to
successfully implement facility expansions and new facility projects;
our ability to increase prices, contain costs and improve productivity;
changes in capital availability or cost, including interest rate
fluctuations; volatility of global credit markets; cybersecurity threats
that could impact our networks and reporting systems; fiscal and
monetary policies and other regulations; direct or indirect consequences
of acts of war or terrorism; work stoppages due to labor disputes; and
competition, including technological advances. For additional
information on these and other risks and uncertainties, please see our
filings with the Securities and Exchange Commission, including the
discussion under “Risk Factors” and “Management’s Discussion and
Analysis of Financial Condition and Results of Operations” in our Form
10-Ks and Form 10-Qs. We undertake no obligation to update any
forward-looking statements, whether as a result of new information,
future events or otherwise.
|
|
|
|
|
|
|
|
|
|
|
|
|
AptarGroup, Inc.
|
|
Condensed Consolidated Financial Statements (Unaudited)
|
|
(In Thousands, Except Per Share Data)
|
|
Consolidated Statements of Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
Year Ended
|
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
|
2018
|
|
2017
|
|
|
2018
|
|
2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Sales
|
|
|
$
|
685,028
|
|
|
$
|
625,895
|
|
|
|
$
|
2,764,761
|
|
|
$
|
2,469,283
|
|
|
Cost of Sales (exclusive of depreciation and amortization shown
below) (1)
|
|
|
|
457,516
|
|
|
|
410,941
|
|
|
|
|
1,812,961
|
|
|
|
1,603,070
|
|
|
Selling, Research & Development and Administrative (2)
|
|
|
|
106,809
|
|
|
|
95,150
|
|
|
|
|
429,955
|
|
|
|
387,424
|
|
|
Depreciation and Amortization
|
|
|
|
48,614
|
|
|
|
38,434
|
|
|
|
|
171,747
|
|
|
|
153,094
|
|
|
Restructuring Initiatives
|
|
|
|
15,827
|
|
|
|
2,208
|
|
|
|
|
63,829
|
|
|
|
2,208
|
|
|
Operating Income
|
|
|
|
56,262
|
|
|
|
79,162
|
|
|
|
|
286,269
|
|
|
|
323,487
|
|
|
Other Income/(Expense):
|
|
|
|
|
|
|
|
|
|
|
|
Interest Expense
|
|
|
|
(7,872
|
)
|
|
|
(14,890
|
)
|
|
|
|
(32,626
|
)
|
|
|
(40,597
|
)
|
|
Interest Income
|
|
|
|
750
|
|
|
|
3,384
|
|
|
|
|
7,056
|
|
|
|
5,470
|
|
|
Equity in Results of Affiliates
|
|
|
|
(99
|
)
|
|
|
(87
|
)
|
|
|
|
(229
|
)
|
|
|
(229
|
)
|
|
Miscellaneous, net (3)
|
|
|
|
9,922
|
|
|
|
8,690
|
|
|
|
|
5,550
|
|
|
|
6,694
|
|
|
Income before Income Taxes
|
|
|
|
58,963
|
|
|
|
76,259
|
|
|
|
|
266,020
|
|
|
|
294,825
|
|
|
Provision for Income Taxes
|
|
|
|
18,288
|
|
|
|
26,753
|
|
|
|
|
71,254
|
|
|
|
74,796
|
|
|
Net Income
|
|
|
$
|
40,675
|
|
|
$
|
49,506
|
|
|
|
$
|
194,766
|
|
|
$
|
220,029
|
|
|
Net Income Attributable to Noncontrolling Interests
|
|
|
|
(1
|
)
|
|
|
7
|
|
|
|
|
(21
|
)
|
|
|
1
|
|
|
Net Income Attributable to AptarGroup, Inc.
|
|
|
$
|
40,674
|
|
|
$
|
49,513
|
|
|
|
$
|
194,745
|
|
|
$
|
220,030
|
|
|
Net Income Attributable to AptarGroup, Inc. per Common Share:
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
$
|
0.65
|
|
|
$
|
0.80
|
|
|
|
$
|
3.12
|
|
|
$
|
3.52
|
|
|
Diluted
|
|
|
$
|
0.62
|
|
|
$
|
0.77
|
|
|
|
$
|
3.00
|
|
|
$
|
3.41
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average Numbers of Shares Outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
|
62,834
|
|
|
|
61,944
|
|
|
|
|
62,437
|
|
|
|
62,435
|
|
|
Diluted
|
|
|
|
65,344
|
|
|
|
64,528
|
|
|
|
|
64,958
|
|
|
|
64,596
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes to the Condensed Consolidated Financial Statements:
|
|
(1) For the quarter and year ended December 31, 2018, Cost of Sales
included the effect of approximately $10.8 million and $14.2
million, respectively, of purchase accounting adjustments to
inventory related to acquisitions.
|
|
|
|
(2) For the quarter and year ended December 31, 2018, Selling,
Research & Development and Administrative included approximately
$0.1 million and $9.6 million, respectively, of acquisition costs.
|
|
|
|
(3) For the quarter and year ended December 31, 2017, Miscellaneous,
net included approximately $10.6 million of gain on an insurance
recovery.
|
|
|
|
AptarGroup, Inc.
|
|
Condensed Consolidated Financial Statements (Unaudited)
|
|
(continued)
|
|
($ In Thousands)
|
|
Consolidated Balance Sheets
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2018
|
|
|
December 31, 2017
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and Equivalents
|
|
|
$
|
261,823
|
|
|
$
|
712,640
|
|
Receivables, net
|
|
|
|
569,630
|
|
|
|
510,426
|
|
Inventories
|
|
|
|
381,110
|
|
|
|
337,216
|
|
Other Current Assets
|
|
|
|
118,245
|
|
|
|
109,791
|
|
Total Current Assets
|
|
|
|
1,330,808
|
|
|
|
1,670,073
|
|
Net Property, Plant and Equipment
|
|
|
|
991,613
|
|
|
|
867,906
|
|
Goodwill
|
|
|
|
712,095
|
|
|
|
443,887
|
|
Other Assets
|
|
|
|
343,219
|
|
|
|
155,957
|
|
Total Assets
|
|
|
$
|
3,377,735
|
|
|
$
|
3,137,823
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-Term Obligations
|
|
|
$
|
163,971
|
|
|
$
|
66,169
|
|
Accounts Payable and Accrued Liabilities
|
|
|
|
525,199
|
|
|
|
461,579
|
|
Total Current Liabilities
|
|
|
|
689,170
|
|
|
|
527,748
|
|
Long-Term Obligations
|
|
|
|
1,125,993
|
|
|
|
1,191,146
|
|
Deferred Liabilities
|
|
|
|
139,701
|
|
|
|
106,881
|
|
Total Liabilities
|
|
|
|
1,954,864
|
|
|
|
1,825,775
|
|
|
|
|
|
|
|
|
|
AptarGroup, Inc. Stockholders' Equity
|
|
|
|
1,422,556
|
|
|
|
1,311,738
|
|
Noncontrolling Interests in Subsidiaries
|
|
|
|
315
|
|
|
|
310
|
|
Total Equity
|
|
|
|
1,422,871
|
|
|
|
1,312,048
|
|
|
|
|
|
|
|
|
|
Total Liabilities and Equity
|
|
|
$
|
3,377,735
|
|
|
$
|
3,137,823
|
|
|
|
|
|
|
|
|
|
|
|
AptarGroup, Inc.
|
|
Reconciliation of Adjusted EBIT and Adjusted EBITDA to Net Income
(Unaudited)
|
|
($ In Thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
|
December 31, 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Food +
|
|
|
Corporate &
|
|
|
|
|
|
|
|
Consolidated
|
|
|
Beauty + Home
|
|
|
Pharma
|
|
|
Beverage
|
|
|
Other
|
|
|
Net Interest
|
|
Net Sales
|
|
|
$
|
685,028
|
|
|
|
|
337,913
|
|
|
|
|
255,801
|
|
|
|
|
91,314
|
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported net income
|
|
|
$
|
40,675
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported income taxes
|
|
|
|
18,288
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported income before income taxes
|
|
|
|
58,963
|
|
|
|
|
8,755
|
|
|
|
|
67,635
|
|
|
|
|
2,220
|
|
|
|
|
(12,525
|
)
|
|
|
|
(7,122
|
)
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring initiatives
|
|
|
|
15,827
|
|
|
|
|
13,743
|
|
|
|
|
(7
|
)
|
|
|
|
(122
|
)
|
|
|
|
2,213
|
|
|
|
|
|
Transaction costs related to acquisitions
|
|
|
|
72
|
|
|
|
|
|
|
|
|
|
|
|
|
|
72
|
|
|
|
|
|
Purchase accounting adjustments related to acquired companies'
inventory
|
|
|
|
10,766
|
|
|
|
|
|
|
|
9,311
|
|
|
|
|
1,455
|
|
|
|
|
|
|
|
|
Adjusted earnings before income taxes
|
|
|
|
85,628
|
|
|
|
|
22,498
|
|
|
|
|
76,939
|
|
|
|
|
3,553
|
|
|
|
|
(10,240
|
)
|
|
|
|
(7,122
|
)
|
|
Interest expense
|
|
|
|
7,872
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7,872
|
|
|
Interest income
|
|
|
|
(750
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(750
|
)
|
|
Adjusted earnings before net interest and taxes (Adjusted EBIT)
|
|
|
|
92,750
|
|
|
|
|
22,498
|
|
|
|
|
76,939
|
|
|
|
|
3,553
|
|
|
|
|
(10,240
|
)
|
|
|
|
-
|
|
|
Depreciation and amortization
|
|
|
|
48,614
|
|
|
|
|
22,273
|
|
|
|
|
16,058
|
|
|
|
|
7,752
|
|
|
|
|
2,531
|
|
|
|
|
-
|
|
|
Adjusted earnings before net interest, taxes, depreciation and
amortization (Adjusted EBITDA)
|
|
|
$
|
141,364
|
|
|
|
$
|
44,771
|
|
|
|
$
|
92,997
|
|
|
|
$
|
11,305
|
|
|
|
$
|
(7,709
|
)
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA margins (Adjusted EBITDA / Reported Net Sales)
|
|
|
|
20.6
|
%
|
|
|
|
13.2
|
%
|
|
|
|
36.4
|
%
|
|
|
|
12.4
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
|
December 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Food +
|
|
|
Corporate &
|
|
|
|
|
|
|
|
Consolidated
|
|
|
Beauty + Home
|
|
|
Pharma
|
|
|
Beverage
|
|
|
Other
|
|
|
Net Interest
|
|
Net Sales
|
|
|
$
|
625,895
|
|
|
|
|
335,473
|
|
|
|
|
207,719
|
|
|
|
|
82,703
|
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported net income
|
|
|
$
|
49,506
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported income taxes
|
|
|
|
26,753
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported income before income taxes
|
|
|
|
76,259
|
|
|
|
|
24,028
|
|
|
|
|
60,502
|
|
|
|
|
5,119
|
|
|
|
|
(1,884
|
)
|
|
|
|
(11,506
|
)
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring initiatives
|
|
|
|
2,208
|
|
|
|
|
529
|
|
|
|
|
|
|
|
1,679
|
|
|
|
|
|
|
|
|
Gain on insurance recovery
|
|
|
|
(10,648
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
(10,648
|
)
|
|
|
|
|
Adjusted earnings before income taxes
|
|
|
|
67,819
|
|
|
|
|
24,557
|
|
|
|
|
60,502
|
|
|
|
|
6,798
|
|
|
|
|
(12,532
|
)
|
|
|
|
(11,506
|
)
|
|
Interest expense
|
|
|
|
14,890
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14,890
|
|
|
Interest income
|
|
|
|
(3,384
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3,384
|
)
|
|
Adjusted earnings before net interest and taxes (Adjusted EBIT)
|
|
|
|
79,325
|
|
|
|
|
24,557
|
|
|
|
|
60,502
|
|
|
|
|
6,798
|
|
|
|
|
(12,532
|
)
|
|
|
|
-
|
|
|
Depreciation and amortization
|
|
|
|
38,434
|
|
|
|
|
19,405
|
|
|
|
|
10,681
|
|
|
|
|
6,349
|
|
|
|
|
1,999
|
|
|
|
|
-
|
|
|
Adjusted earnings before net interest, taxes, depreciation and
amortization (Adjusted EBITDA)
|
|
|
$
|
117,759
|
|
|
|
$
|
43,962
|
|
|
|
$
|
71,183
|
|
|
|
$
|
13,147
|
|
|
|
$
|
(10,533
|
)
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA margins (Adjusted EBITDA / Reported Net Sales)
|
|
|
|
18.8
|
%
|
|
|
|
13.1
|
%
|
|
|
|
34.3
|
%
|
|
|
|
15.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AptarGroup, Inc.
|
|
Reconciliation of Adjusted EBIT and Adjusted EBITDA to Net Income
(Unaudited)
|
|
($ In Thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
|
|
December 31, 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beauty +
|
|
|
|
|
|
Food +
|
|
|
Corporate &
|
|
|
|
|
|
|
|
Consolidated
|
|
|
Home
|
|
|
Pharma
|
|
|
Beverage
|
|
|
Other
|
|
|
Net Interest
|
|
Net Sales
|
|
|
$
|
2,764,761
|
|
|
|
|
1,426,382
|
|
|
|
|
954,652
|
|
|
|
|
383,727
|
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported net income
|
|
|
$
|
194,766
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported income taxes
|
|
|
|
71,254
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported income before income taxes
|
|
|
|
266,020
|
|
|
|
|
49,443
|
|
|
|
|
276,550
|
|
|
|
|
23,956
|
|
|
|
|
(58,359
|
)
|
|
|
|
(25,570
|
)
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring initiatives
|
|
|
|
63,829
|
|
|
|
|
52,244
|
|
|
|
|
3,589
|
|
|
|
|
4,185
|
|
|
|
|
3,811
|
|
|
|
|
|
Transaction costs related to acquisitions
|
|
|
|
9,598
|
|
|
|
|
574
|
|
|
|
|
|
|
|
|
|
|
9,024
|
|
|
|
|
|
Purchase accounting adjustments related to acquired companies'
inventory
|
|
|
|
14,172
|
|
|
|
|
119
|
|
|
|
|
12,072
|
|
|
|
|
1,981
|
|
|
|
|
|
|
|
|
Adjusted earnings before income taxes
|
|
|
|
353,619
|
|
|
|
|
102,380
|
|
|
|
|
292,211
|
|
|
|
|
30,122
|
|
|
|
|
(45,524
|
)
|
|
|
|
(25,570
|
)
|
|
Interest expense
|
|
|
|
32,626
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
32,626
|
|
|
Interest income
|
|
|
|
(7,056
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(7,056
|
)
|
|
Adjusted earnings before net interest and taxes (Adjusted EBIT)
|
|
|
|
379,189
|
|
|
|
|
102,380
|
|
|
|
|
292,211
|
|
|
|
|
30,122
|
|
|
|
|
(45,524
|
)
|
|
|
|
-
|
|
|
Depreciation and amortization
|
|
|
|
171,747
|
|
|
|
|
83,546
|
|
|
|
|
51,495
|
|
|
|
|
27,467
|
|
|
|
|
9,239
|
|
|
|
|
-
|
|
|
Adjusted earnings before net interest, taxes, depreciation and
amortization (Adjusted EBITDA)
|
|
|
$
|
550,936
|
|
|
|
$
|
185,926
|
|
|
|
$
|
343,706
|
|
|
|
$
|
57,589
|
|
|
|
$
|
(36,285
|
)
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA margins (Adjusted EBITDA / Reported Net Sales)
|
|
|
|
19.9
|
%
|
|
|
|
13.0
|
%
|
|
|
|
36.0
|
%
|
|
|
|
15.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended
|
|
|
|
|
December 31, 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Beauty +
|
|
|
|
|
|
Food +
|
|
|
Corporate &
|
|
|
|
|
|
|
|
Consolidated
|
|
|
Home
|
|
|
Pharma
|
|
|
Beverage
|
|
|
Other
|
|
|
Net Interest
|
|
Net Sales
|
|
|
$
|
2,469,283
|
|
|
|
|
1,313,786
|
|
|
|
|
805,880
|
|
|
|
|
349,617
|
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported net income
|
|
|
$
|
220,029
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported income taxes
|
|
|
|
74,796
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported income before income taxes
|
|
|
|
294,825
|
|
|
|
|
93,276
|
|
|
|
|
234,790
|
|
|
|
|
36,504
|
|
|
|
|
(34,618
|
)
|
|
|
|
(35,127
|
)
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring initiatives
|
|
|
|
2,208
|
|
|
|
|
529
|
|
|
|
|
|
|
|
1,679
|
|
|
|
|
|
|
|
|
Gain on insurance recovery
|
|
|
|
(10,648
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
(10,648
|
)
|
|
|
|
|
Adjusted earnings before income taxes
|
|
|
|
286,385
|
|
|
|
|
93,805
|
|
|
|
|
234,790
|
|
|
|
|
38,183
|
|
|
|
|
(45,266
|
)
|
|
|
|
(35,127
|
)
|
|
Interest expense
|
|
|
|
40,597
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40,597
|
|
|
Interest income
|
|
|
|
(5,470
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5,470
|
)
|
|
Adjusted earnings before net interest and taxes (Adjusted EBIT)
|
|
|
|
321,512
|
|
|
|
|
93,805
|
|
|
|
|
234,790
|
|
|
|
|
38,183
|
|
|
|
|
(45,266
|
)
|
|
|
|
-
|
|
|
Depreciation and amortization
|
|
|
|
153,094
|
|
|
|
|
79,422
|
|
|
|
|
41,143
|
|
|
|
|
24,720
|
|
|
|
|
7,809
|
|
|
|
|
-
|
|
|
Adjusted earnings before net interest, taxes, depreciation and
amortization (Adjusted EBITDA)
|
|
|
$
|
474,606
|
|
|
|
$
|
173,227
|
|
|
|
$
|
275,933
|
|
|
|
$
|
62,903
|
|
|
|
$
|
(37,457
|
)
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA margins (Adjusted EBITDA / Reported Net Sales)
|
|
|
|
19.2
|
%
|
|
|
|
13.2
|
%
|
|
|
|
34.2
|
%
|
|
|
|
18.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AptarGroup, Inc.
|
|
Reconciliation of Adjusted Earnings Per Diluted Share (Unaudited)
|
|
(In Thousands, Except Per Share Data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
Year Ended
|
|
|
|
|
December 31,
|
|
|
December 31,
|
|
|
|
|
2018
|
|
2017
|
|
|
2018
|
|
2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before Income Taxes
|
|
|
$
|
58,963
|
|
|
$
|
76,259
|
|
|
|
$
|
266,020
|
|
|
$
|
294,825
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
Restructuring initiatives
|
|
|
|
15,827
|
|
|
|
2,208
|
|
|
|
|
63,829
|
|
|
|
2,208
|
|
|
Transaction costs related to acquisitions
|
|
|
|
72
|
|
|
|
|
|
|
9,598
|
|
|
|
|
Purchase accounting adjustments related to acquired companies'
inventory
|
|
|
|
10,766
|
|
|
|
|
|
|
14,172
|
|
|
|
|
Gain on insurance recovery
|
|
|
|
|
|
(10,648
|
)
|
|
|
|
|
|
(10,648
|
)
|
|
Foreign currency effects (1)
|
|
|
|
|
|
(2,584
|
)
|
|
|
|
|
|
9,123
|
|
|
Adjusted Income before Income Taxes
|
|
|
$
|
85,628
|
|
|
$
|
65,235
|
|
|
|
$
|
353,619
|
|
|
$
|
295,508
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for Income Taxes
|
|
|
$
|
18,288
|
|
|
$
|
26,753
|
|
|
|
$
|
71,254
|
|
|
$
|
74,796
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
Net effect of items included in the Provision for Income Taxes (2)
|
|
|
|
|
|
(7,900
|
)
|
|
|
|
|
|
(7,900
|
)
|
|
Restructuring initiatives
|
|
|
|
4,447
|
|
|
|
642
|
|
|
|
|
17,936
|
|
|
|
642
|
|
|
Transaction costs related to acquisitions
|
|
|
|
-
|
|
|
|
|
|
|
1,475
|
|
|
|
|
Purchase accounting adjustments related to acquired companies'
inventory
|
|
|
|
2,466
|
|
|
|
|
|
|
3,219
|
|
|
|
|
Gain on insurance recovery
|
|
|
|
|
|
(3,666
|
)
|
|
|
|
|
|
(3,666
|
)
|
|
Foreign currency effects (1)
|
|
|
|
|
|
(415
|
)
|
|
|
|
|
|
2,706
|
|
|
Adjusted Provision for Income Taxes
|
|
|
$
|
25,201
|
|
|
$
|
15,414
|
|
|
|
$
|
93,884
|
|
|
$
|
66,578
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income Attributable to Noncontrolling Interests
|
|
|
$
|
(1
|
)
|
|
$
|
7
|
|
|
|
$
|
(21
|
)
|
|
$
|
1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income Attributable to AptarGroup, Inc.
|
|
|
$
|
40,674
|
|
|
$
|
49,513
|
|
|
|
$
|
194,745
|
|
|
$
|
220,030
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
Net effect of items included in the Provision for Income Taxes (2)
|
|
|
|
|
|
7,900
|
|
|
|
|
|
|
7,900
|
|
|
Restructuring initiatives
|
|
|
|
11,380
|
|
|
|
1,566
|
|
|
|
|
45,893
|
|
|
|
1,566
|
|
|
Transaction costs related to acquisitions
|
|
|
|
72
|
|
|
|
|
|
|
8,123
|
|
|
|
|
Purchase accounting adjustments related to acquired companies'
inventory
|
|
|
|
8,300
|
|
|
|
|
|
|
10,953
|
|
|
|
|
Gain on insurance recovery
|
|
|
|
|
|
(6,982
|
)
|
|
|
|
|
|
(6,982
|
)
|
|
Foreign currency effects (1)
|
|
|
|
|
|
(2,169
|
)
|
|
|
|
|
|
6,417
|
|
|
Adjusted Net Income Attributable to AptarGroup, Inc.
|
|
|
$
|
60,426
|
|
|
$
|
49,828
|
|
|
|
$
|
259,714
|
|
|
$
|
228,931
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average Number of Diluted Shares Outstanding
|
|
|
|
65,344
|
|
|
|
64,528
|
|
|
|
|
64,958
|
|
|
|
64,596
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income Attributable to AptarGroup, Inc. Per Diluted Share
|
|
|
$
|
0.62
|
|
|
$
|
0.77
|
|
|
|
$
|
3.00
|
|
|
$
|
3.41
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
Net effect of items included in the Provision for Income Taxes (2)
|
|
|
|
-
|
|
|
|
0.12
|
|
|
|
|
-
|
|
|
|
0.12
|
|
|
Restructuring initiatives
|
|
|
|
0.17
|
|
|
|
0.03
|
|
|
|
|
0.71
|
|
|
|
0.02
|
|
|
Transaction costs related to acquisitions
|
|
|
|
-
|
|
|
|
|
|
|
0.12
|
|
|
|
|
Purchase accounting adjustments related to acquired companies'
inventory
|
|
|
|
0.13
|
|
|
|
|
|
|
0.17
|
|
|
|
|
Gain on insurance recovery
|
|
|
|
|
|
(0.11
|
)
|
|
|
|
|
|
(0.11
|
)
|
|
Foreign currency effects (1)
|
|
|
|
|
|
(0.04
|
)
|
|
|
|
|
|
0.10
|
|
|
Adjusted Net Income Attributable to AptarGroup, Inc. Per Diluted
Share
|
|
|
$
|
0.92
|
|
|
$
|
0.77
|
|
|
|
$
|
4.00
|
|
|
$
|
3.54
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Foreign currency effects are approximations of the
adjustment necessary to state the prior year earnings and earnings
per share using current period foreign currency exchange rates.
|
|
|
|
(2) Items included in the Provision for Income Taxes primarily
reflect the impact of tax reform legislation enacted in the fourth
quarter of 2017.
|
|
|
|
AptarGroup, Inc.
|
|
Reconciliation of Adjusted Earnings Per Diluted Share (Unaudited)
|
|
(In Thousands, Except Per Share Data)
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
|
|
|
March 31,
|
|
|
|
|
Expected 2019
|
|
|
2018
|
|
|
|
|
|
|
|
|
|
Income before Income Taxes
|
|
|
|
|
|
$
|
81,217
|
|
|
|
|
|
|
|
|
|
|
Adjustments:
|
|
|
|
|
|
|
|
Restructuring initiatives
|
|
|
|
|
|
|
5,936
|
|
|
Foreign currency effects (1)
|
|
|
|
|
|
|
(4,951
|
)
|
|
Adjusted Income before Income Taxes
|
|
|
|
|
|
$
|
82,202
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for Income Taxes
|
|
|
|
|
|
$
|
21,929
|
|
|
|
|
|
|
|
|
|
|
Adjustments:
|
|
|
|
|
|
|
|
Restructuring initiatives
|
|
|
|
|
|
|
1,602
|
|
|
Foreign currency effects (1)
|
|
|
|
|
|
|
(1,222
|
)
|
|
Adjusted Provision for Income Taxes
|
|
|
|
|
|
$
|
22,309
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Loss Attributable to Noncontrolling Interests
|
|
|
|
|
|
$
|
12
|
|
|
|
|
|
|
|
|
|
|
Net Income Attributable to AptarGroup, Inc.
|
|
|
|
|
|
$
|
59,300
|
|
|
|
|
|
|
|
|
|
|
Adjustments:
|
|
|
|
|
|
|
|
Restructuring initiatives
|
|
|
|
|
|
|
4,334
|
|
|
Foreign currency effects (1)
|
|
|
|
|
|
|
(3,729
|
)
|
|
Adjusted Net Income Attributable to AptarGroup, Inc.
|
|
|
|
|
|
$
|
59,905
|
|
|
|
|
|
|
|
|
|
|
Average Number of Diluted Shares Outstanding
|
|
|
|
|
|
|
64,414
|
|
|
|
|
|
|
|
|
|
|
Net Income Attributable to AptarGroup, Inc. Per Diluted Share (2)
|
|
|
$
|
0.95 - $1.00
|
|
|
$
|
0.92
|
|
|
|
|
|
|
|
|
|
|
Adjustments:
|
|
|
|
|
|
|
|
Restructuring initiatives
|
|
|
|
|
|
|
0.07
|
|
|
Foreign currency effects (1)
|
|
|
|
|
|
|
(0.06
|
)
|
|
Adjusted Net Income Attributable to AptarGroup, Inc. Per Diluted
Share (2)
|
|
|
$
|
0.95 - $1.00
|
|
|
$
|
0.93
|
|
|
|
|
|
|
|
|
|
|
(1) Foreign currency effects are approximations of the adjustment
necessary to state the prior year earnings per share using foreign
currency exchange rates as of January 31, 2019.
|
|
|
|
(2) AptarGroup’s expected earnings per share range for the first
quarter of 2019 is based on an effective tax rate range of 29% to
31%. This tax rate range compares to our first quarter of 2018
effective tax rate of 27% on both reported and adjusted earnings per
share.
|
|
|

View source version on businesswire.com: https://www.businesswire.com/news/home/20190220005937/en/
Source: AptarGroup, Inc.
Investor Relations Contact:
Matt
DellaMaria
matt.dellamaria@aptar.com
815-477-0424
Media Contact:
Katie Reardon
katie.reardon@aptar.com
815-477-0424